Headache and Migraine

Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.

Researchers evaluated whether blood levels of PACAP could serve as a biomarker for parasympathetic activation in migraine headaches.

Triptans are contraindicated with certain CV risk factors, however, there are few data looking at the rate of triptans use among this population.

Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.

A small study of 108 patients evaluated if caffeine cessation for 2 weeks or longer could affect outcomes of acute migraine treatment.

A study of U.S. Armed Forces asks if severity of traumatic brain injury impacts the likelihood of developing headache or migraine.

New research covers treating MS early, identifying those at risk for AED-induced psychosis, & selecting a drug for epilepsy patients with migraines.

Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.

Who is most likely to be affected by Alice in Wonderland syndrome? Would you consider a toxicology screen or neuroimaging for afflicted patients?

Data from the Nurses’ Health Study II evaluated the risk of cardiovascular disease, myocardial infarction, and stroke in women with migraine.

Was longer treatment duration with noninvasive vagus nerve stimulation associated with a clinically significant reduction in headache days?

Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.

Neurologic conditions, such as epilepsy, migraine, and stroke, often have real-world consequences, such as those described in three new studies.

Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.

Two authors of the updated AAN guidelines for treatment with botulinum neurotoxin discussed their findings and potential avenues of further research.

Our Feb. news & research include two new migraine drugs, the stroke-Parkinson link, and the potential of an anticancer drug to prevent Alzheimer.

Does prophylactic onabotulinumtoxinA benefit patients with migraine or are they experiencing a placebo effect?

Our Dec. news & research list includes groundbreaking research from AES 2015 as well as a few potential neurodegeneration biomarkers.

Our blogger delves into the pros and cons of acupuncture as a complementary treatment for migraine.

A blood lipid could hold the keys to diagnosing migraines.

How do you prescribe triptans – generic meds, as monotherapy, via injection? Learn the best approach for your migraine patients.

Our blogger discusses a possible resolution to this much-debated topic.

When medications no longer offer relief to your patients with migraines, surgical treatment may be the answer.

Neurologists will need to improve documentation for several common diagnoses to make a successful ICD-10 transition. Here are six helpful tips.

Explore recent migraine treatment research on the following slides.